LXRX Stock Analysis: Buy, Sell, or Hold?
LXRX - Lexicon Pharmaceuticals, Inc.
$2.23
-0.10 (-4.29%)
▼
5d:
+11.5%
30d:
+21.2%
90d:
+70.23%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Accumulation
LXRX is down 4.5% this week, but smart money is accumulating calls. Top strike: $1.5 2026-06-18 with 481 OI. Call ratio: 81% View Scanner →
Strength: 5.3/10
Get Alerted When LXRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
7 traders called LXRX this week
88% bullish • 1 bearish
88% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: LXRX is 7.2% above its trading range ($2.08). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: LXRX is 7.2% above its trading range ($2.08). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: LXRX is currently trading at $2.23, which is considered extended relative to its 30-day fair value range of $1.56 to $2.08.
Technical Outlook: Technically, LXRX is in a strong uptrend. Immediate support is located at $1.52, while resistance sits at $2.53. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: LXRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.72 (+66.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LXRX is in a strong uptrend. Immediate support is located at $1.52, while resistance sits at $2.53. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: LXRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.72 (+66.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.56 -
$2.08
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price extended above range (+7.2% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.3%)
- BULLISH: Trading 66.8% below Wall St target ($3.72)
Trading Range Analysis
30-Day Trading Range
$1.56 -
$2.08
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.52
Resistance Level
$2.53
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.81
Wall Street Target
$3.72
(+66.8%)
Revenue Growth (YoY)
-79.3%
Earnings Growth (YoY)
-63.4%
Profit Margin
-101.1%
Share & Embed Analysis
Last updated: May 18, 2026 8:26 AM ET
Data refreshes hourly during market hours. Next update: 9:26 AM
Data refreshes hourly during market hours. Next update: 9:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LXRX showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Raymond Debbane
BUY
2000 shares
2026-02-25
Raymond Debbane
BUY
100000 shares
2026-02-23
Raymond Debbane
BUY
100000 shares
2026-02-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$126 | 48 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$106 | 56 HOLD |